Entity Common Stock, Shares Outstanding of Medpace Holdings, Inc. from Q3 2016 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Medpace Holdings, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q3 2016 to Q3 2025.
  • Medpace Holdings, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 17 Oct 2025 was 28.2M shares, a 9.37% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Medpace Holdings, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 28.2M -2.91M -9.37% 17 Oct 2025 10-Q 23 Oct 2025
Q2 2025 28.1M -2.91M -9.38% 18 Jul 2025 10-Q 22 Jul 2025
Q1 2025 28.7M -2.24M -7.24% 18 Apr 2025 10-Q 22 Apr 2025
Q4 2024 30.5M -292K -0.95% 07 Feb 2025 10-K 11 Feb 2025
Q3 2024 31.1M +398K +1.3% 18 Oct 2024 10-Q 22 Oct 2024
Q2 2024 31M +439K +1.44% 19 Jul 2024 10-Q 23 Jul 2024
Q1 2024 31M +484K +1.59% 19 Apr 2024 10-Q 23 Apr 2024
Q4 2023 30.8M -291K -0.94% 09 Feb 2024 10-K 13 Feb 2024
Q3 2023 30.7M -416K -1.34% 20 Oct 2023 10-Q 24 Oct 2023
Q2 2023 30.6M -436K -1.41% 21 Jul 2023 10-Q 25 Jul 2023
Q1 2023 30.5M -3.15M -9.36% 21 Apr 2023 10-Q 25 Apr 2023
Q4 2022 31.1M -4.18M -11.9% 10 Feb 2023 10-K 14 Feb 2023
Q3 2022 31.1M -4.84M -13.5% 21 Oct 2022 10-Q 25 Oct 2022
Q2 2022 31M -4.82M -13.5% 22 Jul 2022 10-Q 26 Jul 2022
Q1 2022 33.6M -2.33M -6.46% 22 Apr 2022 10-Q 26 Apr 2022
Q4 2021 35.2M -506K -1.42% 11 Feb 2022 10-K 15 Feb 2022
Q3 2021 35.9M +168K +0.47% 22 Oct 2021 10-Q 26 Oct 2021
Q2 2021 35.8M +411K +1.16% 23 Jul 2021 10-Q 27 Jul 2021
Q1 2021 36M +598K +1.69% 23 Apr 2021 10-Q 27 Apr 2021
Q4 2020 35.7M 12 Feb 2021 10-K 16 Feb 2021
Q3 2020 35.8M -259K -0.72% 23 Oct 2020 10-Q 27 Oct 2020
Q2 2020 35.4M -488K -1.36% 24 Jul 2020 10-Q 28 Jul 2020
Q1 2020 35.4M -444K -1.24% 24 Apr 2020 10-Q 29 Apr 2020
Q3 2019 36M +425K +1.2% 25 Oct 2019 10-Q 29 Oct 2019
Q2 2019 35.9M +341K +0.96% 26 Jul 2019 10-Q 30 Jul 2019
Q1 2019 35.8M +311K +0.88% 26 Apr 2019 10-Q 30 Apr 2019
Q3 2018 35.6M -2M -5.32% 26 Oct 2018 10-Q 30 Oct 2018
Q2 2018 35.6M -3.93M -9.96% 27 Jul 2018 10-Q 31 Jul 2018
Q1 2018 35.5M -5.24M -12.9% 27 Apr 2018 10-Q 01 May 2018
Q3 2017 37.6M -3.11M -7.65% 27 Oct 2017 10-Q 31 Oct 2017
Q2 2017 39.5M 28 Jul 2017 10-Q 01 Aug 2017
Q1 2017 40.7M 30 Apr 2017 10-Q 02 May 2017
Q3 2016 40.7M 31 Oct 2016 10-Q 03 Nov 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.